Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia.
Inactivation of p16ink4A and other tumor suppressor genes has been associated with promoter region hypermethylation in neoplasia. However, direct proof for aberrant DNA methylation as an independent event for loss of gene function has been difficult to obtain. We addressed this question in the colon carcinoma cell line HCT116, which contains one allele of p16ink4A with a coding region frameshift mutation and one wild-type allele. Neither allele contains a mutation in the proximal promoter region. The promoter of the wild-type allele, but not the mutant allele, is hypermethylated, and only the mutant allele is expressed. Transcription from the methylated/wild-type allele was restored after cell treatment with the demethylating agent 5-aza-2'-deoxycytidine. Thus, in neoplastic cells, stable allele-specific loss of transcription may arise from aberrant methylation of a nonmutated promoter region, identifying hypermethylation as a direct mechanism for tumor suppressor gene inactivation.
Myöhänen
S K
SK
The Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Baylin
S B
SB
Herman
J G
JG
D000483:Alleles; D001483:Base Sequence; D003110:Colonic Neoplasms / Q000235:genetics*; D018899:CpG Islands; D018844:Cyclin-Dependent Kinases / Q000235:genetics*; D019175:DNA Methylation; D016368:Frameshift Mutation; D015972:Gene Expression Regulation, Neoplastic; D019942:Genes, p16; D006801:Humans; D011401:Promoter Regions, Genetic; D014407:Tumor Cells, Cultured
D018844:Cyclin-Dependent Kinases